# Pilot Study of BOTOX for Migraine Headaches

> **NCT00850421** · NA · TERMINATED · sponsor: **HealthPartners Institute** · enrollment: 35 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** Botulinum Toxin Type A

## Key facts

- **NCT ID:** NCT00850421
- **Lead sponsor:** HealthPartners Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-04
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Recently published BOTOX efficacy data and study design deficits.
- **Last updated:** 2018-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00850421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00850421, "Pilot Study of BOTOX for Migraine Headaches". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00850421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*